Serum Amyloid A Correlates With the Osteonecrosis of Femoral Head by Affecting Bone Metabolism
Authors:
- Xiaoyuan PengXPXiaoyuan Peng
- Yiyang MaYMYiyang Ma
- Yong FengYFYong Feng
Open Access
- 18 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
Abstract
Osteonecrosis of femoral head (ONFH) is a progressive hip joint disease without disease-modifying treatment. Lacking understanding of the pathophysiological process of ONFH has become the humper to develop therapeutic approach. Serum amyloid A (SAA) is an acute phase lipophilic protein during inflammation and we found that SAA is increased for the first time in the serum of ONFH patients through proteomic studies and quantitatively verified by ELISA. Treating rBMSCs with SAA inhibited the osteogenic differentiation via Wnt/β-catenin signaling pathway deactivation and enhanced the adipogenic differentiation via MAPK/PPARγ signaling pathway activation. Finally, bilateral critical-sized calvarial-defect rat model which received SAA treated rBMSCs demonstrated reduction of bone formation when compared to untreated rBMSCs implantation control. Hence, SAA is a vital protein in the physiological process of ONFH and can act as a potential therapeutic target to treat ONFH.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- High Throughput Transcriptome Profiling of Lithium Stimulated Human Mesenchymal Stem Cells Reveals Priming towards Osteoblastic LineagePLOS ONE, 2013
- Wnt/β-Catenin Signaling Enhances Osteoblastogenic Differentiation from Human Periodontal Ligament FibroblastsMolecules and Cells, 2010
- Id4, a New Candidate Gene for Senile Osteoporosis, Acts as a Molecular Switch Promoting Osteoblast DifferentiationPLOS Genetics, 2010
- Inflammatory Biomarker Profiling in Elderly Patients With Acute Hip Fracture Treated With HeparinsClinical and Applied Thrombosis/Hemostasis, 2009
- Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein KinasesJournal of Biological Chemistry, 2005
- High Throughput Proteome Screening for Biomarker DetectionMolecular & Cellular Proteomics, 2005
- Local expression of the serum amyloid A and formyl peptide receptor–like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritisArthritis & Rheumatism, 2004
- Expression of Serum Amyloid A in chondrocytes and myoblasts differentiation and inflammation: possible role in cholesterol homeostasisMatrix Biology, 2004
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Transformation of Amyloid Precursor SAA to Protein AA and Incorporation in Amyloid Fibrils in VivoScandinavian Journal of Immunology, 1985